New tool better predicts COPD risk for people of non-European ancestry Dr. Kamal Kant Kohli13 May 2022 8:00 AM GMTUVA Health researchers and their collaborators have developed a better way to predict the risk of chronic obstructive pulmonary disease (COPD), a...
Alembic Pharma bags USFDA nod for Arformoterol Tartrate Inhalation Solution Ruchika Sharma11 May 2022 7:54 AM GMTThis ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies Private Limited.
Battling Lower Respiratory Tract Infections: Scope of Levofloxacin Dr. Kamal Kant Kohli27 Jan 2022 4:57 AM GMTFluoroquinolones are highly effective antibiotics with many advantageous pharmacokinetic properties including high oral bioavailability, a large...
Alembic Pharma gets USFDA nod for Formoterol Fumarate Inhalation Solution Ruchika Sharma23 Nov 2021 7:22 AM GMTMumbai: Drugmaker, Alembic Pharmaceuticals Limited, today announced that the company has received final approval from the US Food &...
Cipla gets USFDA nod for generic version of Brovana Ruchika Sharma23 Jun 2021 5:30 AM GMTMumbai: Drug major, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application...
Hyperconcentration of lung protein may predict COPD risk: Lancet Hina Zahid5 Jun 2021 4:28 AM GMTMUC5AC is found at elevated levels in smokers who had not yet developed COPD but whose lung function wound up decreasing over the course of the...
Understanding the role of Doxycycline in Management of Infections in Daily Medical Practice Dr.T. Sabesan15 May 2021 6:14 AM GMTDoxycycline is a broad-spectrum antimicrobial agent with activity against gram-positive, gram-negative, atypical bacteria as well as some protozoan...
